Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

510
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
510
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Cancer Therapies02:49

Cancer Therapies

7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short-term low-carbohydrate diet decreases body weight and fat mass but not muscle strength in children and young people with type 1 diabetes.

European journal of clinical nutrition·2025
Same author

Low-carbohydrate diet in children and young people with type 1 diabetes: A randomized controlled trial with cross-over design.

Diabetes research and clinical practice·2024
Same author

Staging for endometrial carcinoma FIGO 2023 and its relevance for clinical practice.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2024
Same author

Use of MALDI-TOF MS technology to evaluate adulteration of small ruminant milk with raw bovine milk.

Journal of dairy science·2022
Same author

Rapid screening of depression and anxiety in cancer patients: Interview validation of emotion thermometers.

Asian journal of psychiatry·2021
Same author

Detection of bovine milk adulteration in caprine milk with N-acetyl carbohydrate biomarkers by using <sup>1</sup>H nuclear magnetic resonance spectroscopy.

Journal of dairy science·2021
Same journal

68Ga-DOTATOC PET/CT - a case report of synchronous oncological duplicity with high expression of somatostatin receptors.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same journal

Differences in the imaging of Erdheim-Chester disease using FDG-PET/CT, NaF-PET/CT examinations, and skeletal scintigraphy. Regression of the disease after treatment with cladribine combined with cyclophosphamide and anakinra.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same journal

From progression to complete remission - a case study of successful pemigatinib treatment in a patient with metastatic FGFR2+ cholangiocarcinoma.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same journal

Second and subsequent lines of systemic therapy in endometrial cancer - a real-life clinical experience.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same journal

Chronic low-grade fever or fever with mild lymphadenopathy may indicate Castleman disease if no malignant, autoimmune, or infectious cause of the lymphadenopathy is identified.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same journal

Clinical presentations of the most common histiocytic disorders.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
See all related articles

Related Experiment Video

Updated: Sep 12, 2025

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

9.9K

Current complex treatment for cervical cancer.

R Soumarová, J Havlík

    Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
    |August 5, 2025
    PubMed
    Summary
    This summary is machine-generated.

    Cervical cancer treatment is evolving, with immunotherapy showing promise alongside radiation therapy for advanced stages. Research is exploring new nonsurgical approaches for better patient outcomes.

    Keywords:
    brachytherapyearly cervical cancerexternal beam radiotherapylocally advanced cervical cancerpembrolizumab

    More Related Videos

    Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
    07:29

    Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

    Published on: April 22, 2019

    11.6K
    An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
    09:48

    An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

    Published on: September 12, 2019

    8.2K

    Related Experiment Videos

    Last Updated: Sep 12, 2025

    Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
    06:11

    Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

    Published on: April 20, 2018

    9.9K
    Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
    07:29

    Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

    Published on: April 22, 2019

    11.6K
    An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
    09:48

    An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

    Published on: September 12, 2019

    8.2K

    Area of Science:

    • Oncology
    • Gynecologic Oncology

    Background:

    • Cervical cancer incidence and mortality are declining but remain significant, particularly in younger populations.
    • Early-stage treatment is typically surgical, while advanced stages utilize radiation and systemic therapies.
    • The role of neoadjuvant systemic therapy and immunotherapy in cervical cancer treatment is under active investigation.

    Purpose of the Study:

    • To summarize current nonsurgical treatment modalities for cervical cancer.
    • To outline emerging therapeutic strategies and future directions in cervical cancer management.

    Main Methods:

    • Review of current literature on cervical cancer therapies.
    • Analysis of systemic therapies including chemotherapy and immunotherapy.
    • Evaluation of radiation therapy combined with systemic treatments.

    Main Results:

    • Immunotherapy is increasingly utilized in metastatic cervical cancer.
    • Combining immunotherapy with radiation therapy improves outcomes in locally advanced disease.
    • Nonsurgical approaches are central to managing advanced cervical cancer.

    Conclusions:

    • Nonsurgical therapies, particularly immunotherapy, are crucial in managing advanced cervical cancer.
    • Further research into neoadjuvant systemic therapy and immunotherapy combinations is warranted.
    • Optimizing current nonsurgical treatments can improve oncological outcomes for cervical cancer patients.